Plasma proteome profiling reveals biomarker patterns associated with prognosis and therapy selection in glioblastoma multiforme patients.
about
Nanobodies and recombinant binders in cell biologyProteinSeq: high-performance proteomic analyses by proximity ligation and next generation sequencingMolecular serum portraits in patients with primary breast cancer predict the development of distant metastasesIdentification of hub genes and regulatory factors of glioblastoma multiforme subgroups by RNA-seq data analysisSerum protein profiling of systemic lupus erythematosus and systemic sclerosis using recombinant antibody microarraysProteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead.Identification of plasma biomarker candidates in glioblastoma using an antibody-array-based proteomic approachIdentification of plasma protein profiles associated with risk groups of prostate cancer patientsSystemic T Cells Immunosuppression of Glioma Stem Cell-Derived Exosomes Is Mediated by Monocytic Myeloid-Derived Suppressor Cells.A Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal Adenocarcinoma.ZIP4 is a novel molecular marker for glioma.Mining genomic patterns in Mycobacterium tuberculosis H37Rv using a web server Tuber-Gene.Affinity proteomics: the role of specific binding reagents in human proteome analysis.Liquid biopsies in patients with diffuse glioma.Emerging circulating biomarkers in glioblastoma: promises and challenges.Anti-inflammatory effect of Qingwen Baidu Decoction (清瘟败毒饮) in sepsis rats.Antibody-Based Proteomics.The Process and Regulatory Components of Inflammation in Brain Oncogenesis.Serum proteome profiling of pancreatitis using recombinant antibody microarrays reveals disease-associated biomarker signatures.
P2860
Q28081411-303D6F06-D86D-47CD-A8E3-1BF346D252D3Q28744412-6E20EA3A-326C-4481-B0BA-E44B654A9457Q30503693-C4290331-31F0-46D4-9801-3C2A6AD84221Q31125309-4E394AAE-754F-4457-AB7E-069F2B3999D4Q33829507-8F221CF0-C875-4315-9DBE-8B6DFB18B808Q33891197-B6D3F61B-3CD8-45E1-969E-ECA9B40D5E51Q33946339-83F2827C-F201-4D92-8156-0622D7121A16Q35940183-9C5D42C3-1603-46EE-B139-6D2D7553AD82Q36255674-83CD27AE-F842-4E2E-BBDC-1A97A6340185Q36261071-56CB41B2-EDB6-4323-9DF1-45A1597FB035Q37021553-B613E600-FA4C-4BAD-87D2-22E57C0E892AQ37319255-AF0D5112-3AD7-4A54-A7C5-D0D82510ECDAQ38042457-75B0E4A3-7CBF-482E-9B28-FABEB262F9FCQ38365590-C484611F-ECD3-4803-B892-E19AA627EBE8Q38591062-1929F18A-D80D-46D3-91B4-BA941A8A4924Q38937474-105584BC-1999-4C49-B435-AF497C6E616DQ38968223-3EF866C9-7151-480A-988A-8CFF32103A29Q39202332-23FD1566-E91A-40FB-953C-46C22AAAD313Q46422293-2FFD6535-A6DA-4360-B776-785FA272CBD0
P2860
Plasma proteome profiling reveals biomarker patterns associated with prognosis and therapy selection in glioblastoma multiforme patients.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Plasma proteome profiling reve ...... oblastoma multiforme patients.
@en
Plasma proteome profiling reve ...... oblastoma multiforme patients.
@nl
type
label
Plasma proteome profiling reve ...... oblastoma multiforme patients.
@en
Plasma proteome profiling reve ...... oblastoma multiforme patients.
@nl
prefLabel
Plasma proteome profiling reve ...... oblastoma multiforme patients.
@en
Plasma proteome profiling reve ...... oblastoma multiforme patients.
@nl
P2093
P2860
P356
P1476
Plasma proteome profiling reve ...... oblastoma multiforme patients.
@en
P2093
Anders Carlsson
Bengt Widegren
Carl A K Borrebaeck
Christer Wingren
Johan Ingvarsson
Oscar Persson
P2860
P304
P356
10.1002/PRCA.200900173
P50
P577
2010-04-07T00:00:00Z